Company: BDRX
Filing Date: 2025-01-21
Form Type: 424B3
Source: 0001214659-25-000934
Chunk: 64

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-21
Form: 424B3
Chunk 64
---
.

b. “”
means any individual or entity including but not limited to any corporation, a limited liability company, an association, a partnership,
an organization, a business, an individual, a governmental or political subdivision thereof or a governmental agency.

c. “,”
“,” and “” refer to a registration effected by preparing and filing one or
more Registration Statements of the Company in compliance with the Securities Act and pursuant to Rule 415 under the Securities Act or
any successor rule providing for offering securities on a continuous basis (“”), and the declaration or ordering
of effectiveness of such Registration Statement(s) by the United States Securities and Exchange Commission (the “”).

d. “” means all of the Commitment Shares and all of the Purchase Shares that may, from time to time, be issued or become
issuable to the Investor under the Purchase Agreement (without regard to any limitation or restriction on purchases), and any and all
shares of capital shares issued or issuable with respect to the Purchase Shares, the Commitment Shares or the Purchase Agreement as a
result of any share split, share dividend, recapitalization, Depositary Share-Ordinary Share ratio change, exchange or similar event or
otherwise, without regard to any limitation on purchases under the Purchase Agreement, in each case until such time as such securities
cease to be Registrable Securities pursuant to Section 2(e).

e. “” means one or more registration statements of the Company covering only the resale of the Registrable Securities,
including, for the avoidance of doubt, any New Registration Statement (as defined below).

2. .

a. The Company shall, within forty-five (45) calendar days after the Execution Date, file with the SEC an initial Registration
Statement on Form F-1 covering the maximum number of Registrable Securities as shall be permitted to be included thereon in accordance
with applicable SEC rules, regulations and interpretations so as to permit the resale of such Registrable Securities by the Investor under
Rule 415 under the Securities Act at then-prevailing market prices (and not fixed prices), as mutually determined by both the Company
and the Investor in consultation with their respective legal counsel; provided, however, the Company may delay filing or suspend the use
of any Registration Statement if the Company determines upon advice of legal counsel, that in order for the registration statement to
not contain a material misstatement or omission, an amendment thereto would be needed, or if the Board of Directors, upon advice of legal
counsel, reasonably believes